Condition guide · 7 min read

TMJ disorder — supplement adjuncts and what to skip

Updated 2026-05-20 · Reviewed by SupplementScore editors · No sponsorships

Temporomandibular joint disorder (TMD) covers a heterogeneous group of conditions affecting the jaw joint and surrounding masticatory muscles. Most cases are myofascial — muscle hyperactivity, clenching, and bruxism — rather than primary joint disease. The decisive interventions are behavioural (parafunctional-habit awareness, stress management), physical therapy with jaw-specific exercise, occlusal splint where indicated, and short courses of NSAIDs. Supplements are adjuncts, with the strongest case in the myofascial subset.

Get the diagnosis right first. Acute jaw locking, sudden bite change, joint clicking with pain progression, or persistent unilateral facial pain warrants dental, oral medicine, or maxillofacial assessment to rule out disc displacement, degenerative joint disease, giant cell arteritis (in older adults), or referred pain from cardiac, ENT, or neurologic sources.

Supplements with credible adjunctive evidence

Tier 1 · Muscle relaxation and sleep

Magnesium glycinate

300–400 mg elemental magnesium at bedtime

Magnesium has muscle-relaxant activity at therapeutic doses and is the supplement with the most plausible mechanism for myofascial TMD. Small trials in nocturnal bruxism suggest reduced muscle activity on EMG with supplementation. The glycinate form is well tolerated. Indirect benefit through better sleep quality (less nocturnal clenching).

Tier 1 · Systemic anti-inflammatory adjunct

Omega-3 (EPA/DHA)

1.5–3 g combined EPA + DHA daily

Omega-3 modulates inflammatory mediators relevant to joint and muscle pain. The TMD-specific trial base is thin, but Maroon's discogenic-pain trial and broader chronic-pain literature support modest analgesic effects at high doses. Pause 1 week before any dental surgery.

Tier 2 · NSAID-sparing analgesic

Curcumin (bioavailable form)

500 mg twice daily of a phospholipid or piperine-enhanced formulation

Bioavailable curcumin formulations have musculoskeletal-pain trials showing efficacy comparable to ibuprofen. The TMD-specific data is small but consistent with the broader joint-pain evidence. Useful when chronic NSAID use is contraindicated. Pause 1–2 weeks pre-surgery.

Tier 1 · Often low; effect on chronic pain modest

Vitamin D3

1000–2000 IU/day, titrated to 25-OH-D 30–50 ng/mL

Low 25-OH-D is associated with more reported chronic pain in observational work; the effect of repletion on chronic pain outcomes is modest at best. Test first and supplement to the normal range. Particularly relevant in patients with concurrent fibromyalgia or widespread pain.

Tier 3 · Some evidence in degenerative TMD specifically

Glucosamine sulphate (if degenerative joint component)

1500 mg/day for 8–12 weeks

Glucosamine has been studied in TMD with degenerative changes (osteoarthritis of the joint) with mixed but slightly positive results in small trials. Less relevant in pure myofascial TMD without imaging-confirmed joint disease. Knee-OA glucosamine data is mixed; the TMD evidence is similarly modest.

What to skip

Practical priority list. Parafunctional-habit awareness and stress management → jaw-specific physical therapy → night guard if bruxism → short course of NSAID or topical NSAID if safe → magnesium glycinate at bedtime → omega-3 → vitamin D repletion if low → bioavailable curcumin if chronic and NSAID-sparing → glucosamine only if imaging confirms degenerative joint changes. If persistent, escalate to dental/oral medicine or maxillofacial assessment.

Sources

Read more: